Leukemia and Therapy
N. B. Alitheen1, S. K. Yeap1, N. H. Faujan1, W. Y. Ho1, B. K. Beh1 & A. R. Mashitoh1 Show affiliations
- Universiti Putra Malaysia, Malaysia
American Journal of Immunology, Volume 7, Issue 4, pp. 54–61 · doi.org/10.3844/ajisp.2011.54.61
Abstract
Problem statement: Leukemia is a cancer which linked intimately with the immune system. It is a group of heterogenous neoplastic disorder of white blood cells characterized by the uncontrolled proliferation and block in differentiation of hematopoeitic cells. Generally, leukemia can be classified into myeloid or lymphoid referring to the type of abnormal cell found most in the blood. Approach: Many drug discovery researches have utilized the leukemic cell lines to screen for their potential as chemotherapy agents for leukemia. Results: The understanding on the types of leukemia and current choice of chemotherapy drugs can help to select the best target cell lines to study and the most suitable chemotherapy drug as positive control. Conclusion/Recommendations: This review cover types of leukemia, current option of chemotherapy drugs and some potential cytotoxic and immunomodulatory natural products targeting leukemic cancer cell line.
Licence and reuse
Free to read. This article carries the publisher’s copyright, as printed on it: © 2011 Science Publications. It is free to read; ask us before reusing it.
How to reuse this articleResponses (0)
About this article
Alitheen, N. B., Yeap, S. K., Faujan, N. H., Ho, W. Y., Beh, B. K. & Mashitoh, A. R. (2011). Leukemia and Therapy. American Journal of Immunology, 7(4), 54–61. https://doi.org/10.3844/ajisp.2011.54.61
- Licence
- © Science Publications
- Issue
- Volume 7, Issue 4
- Policies
- Editorial independenceUse of generative AIData availabilityAppeals and complaints
- Version
- Version of record
